MAY 29, 2009

Company

IGC Pharma, Inc.

Filed

June 1, 2009

Accession Number

0001013594-09-001149

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →